{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:48:03Z","timestamp":1791582483896,"version":"4.3.4"},"reference-count":23,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2019,9,1]]},"DOI":"10.1001\/jamaoncol.2019.1568","type":"journal-article","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T11:00:52Z","timestamp":1563447652000},"page":"1293","source":"Crossref","is-referenced-by-count":93,"title":["Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma"],"prefix":"10.1001","volume":"5","author":[{"given":"Ola","family":"Landgren","sequence":"first","affiliation":[{"name":"Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan N.","family":"Hofmann","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene M.","family":"McShane","sequence":"additional","affiliation":[{"name":"Cancer Epidemiology and Health Services Research Group, Centre for Public Health, Queen\u2019s University, Belfast, Northern Ireland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Santo","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Hultcrantz","sequence":"additional","affiliation":[{"name":"Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Division of Hematology, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Korde","sequence":"additional","affiliation":[{"name":"Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sham","family":"Mailankody","sequence":"additional","affiliation":[{"name":"Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dickran","family":"Kazandjian","sequence":"additional","affiliation":[{"name":"Multiple Myeloma Section, National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Murata","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Thoren","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Ramanathan","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Dogan","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Even","family":"Rustad","sequence":"additional","affiliation":[{"name":"Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney X.","family":"Lu","sequence":"additional","affiliation":[{"name":"Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresia","family":"Akhlaghi","sequence":"additional","affiliation":[{"name":"Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurdur Y.","family":"Kristinsson","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden"},{"name":"Faculty of Medicine, University of Iceland, Reykjavik, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Bj\u00f6rkholm","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Devlin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Purdue","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth M.","family":"Pfeiffer","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingemar","family":"Turesson","sequence":"additional","affiliation":[{"name":"Myeloma Section, Department of Medicine, University Hospital of Malmo, Malmo, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"coi190042r1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017.","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"coi190042r2","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","article-title":"Multiple myeloma.","volume":"111","author":"Kyle","year":"2008","journal-title":"Blood"},{"issue":"5","key":"coi190042r3","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1053\/j.ackd.2012.03.001","article-title":"Myeloma kidney: improving clinical outcomes?","volume":"19","author":"Haynes","year":"2012","journal-title":"Adv Chronic Kidney Dis"},{"issue":"6","key":"coi190042r4","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1158\/1078-0432.CCR-10-1822","article-title":"From myeloma precursor disease to multiple myeloma: new diagnostic concepts and opportunities for early intervention.","volume":"17","author":"Landgren","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"10","key":"coi190042r5","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1038\/bcj.2017.97","article-title":"Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey.","volume":"7","author":"Landgren","year":"2017","journal-title":"Blood Cancer J"},{"issue":"7","key":"coi190042r6","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/leu.2014.34","article-title":"Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey.","volume":"28","author":"Landgren","year":"2014","journal-title":"Leukemia"},{"issue":"3","key":"coi190042r7","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1182\/blood-2013-05-505487","article-title":"Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden.","volume":"123","author":"Turesson","year":"2014","journal-title":"Blood"},{"issue":"13","key":"coi190042r8","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance.","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"coi190042r9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance.","volume":"378","author":"Kyle","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"coi190042r10","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"issue":"4","key":"coi190042r11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1046\/j.1365-2141.2003.04654.x","article-title":"Smoldering multiple myeloma: natural history and recognition of an evolving type.","volume":"123","author":"Rosi\u00f1ol","year":"2003","journal-title":"Br J Haematol"},{"issue":"7","key":"coi190042r12","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.65","article-title":"Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myeloma.","volume":"6","author":"Ravi","year":"2016","journal-title":"Blood Cancer J"},{"issue":"6","key":"coi190042r13","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/s41375-018-0013-4","article-title":"Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression.","volume":"32","author":"Fern\u00e1ndez de Larrea","year":"2018","journal-title":"Leukemia"},{"issue":"9727","key":"coi190042r14","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","article-title":"Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study.","volume":"375","author":"Dispenzieri","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"coi190042r15","doi-asserted-by":"publisher","first-page":"273S","DOI":"10.1016\/S0197-2456(00)00098-2","article-title":"Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.","volume":"21","author":"Prorok","year":"2000","journal-title":"Control Clin Trials"},{"issue":"20","key":"coi190042r16","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"368","key":"coi190042r17","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1080\/01621459.1979.10481038","article-title":"Robust locally weighted regression and smoothing scatterplots.","volume":"74","author":"Cleveland","year":"1979","journal-title":"J Am Stat Assoc"},{"issue":"500","key":"coi190042r18","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1080\/01621459.2012.737745","article-title":"Optimal detection of changepoints with a linear computational cost.","volume":"107","author":"Killick","year":"2012","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"coi190042r19","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1182\/asheducation-2017.1.194","article-title":"Shall we treat smoldering multiple myeloma in the near future?","volume":"2017","author":"Landgren","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"12","key":"coi190042r20","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"22","key":"coi190042r21","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"coi190042r22","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1182\/bloodadvances.2017005934","article-title":"Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma.","volume":"1","author":"Mailankody","year":"2017","journal-title":"Blood Adv"},{"issue":"5","key":"coi190042r23","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1080\/10428194.2017.1361026","article-title":"Host-related immunodeficiency in the development of multiple myeloma.","volume":"59","author":"Dosani","year":"2018","journal-title":"Leuk Lymphoma"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2738419\/jamaoncology_landgren_2019_oi_190042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T11:01:10Z","timestamp":1568286070000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2738419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,1]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2019.1568","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,1]]}}}